COVID-19 VACCINE

To respond to the need for new COVID-19 vaccines that provide enhanced and durable protection against ongoing and future SARS-CoV-2 epidemics, this study is designed to assess the relative efficacy of a nasal vaccine, a next generation candidate COVID-19 vaccine, compared to a currently approved/authorized COVID-19 vaccine in the prevention of symptomatic, polymerase chain reaction (PCR)-confirmed SARS-CoV-2 infection.

You may qualify if you:

  • Are an adult over the age of 65+
  • Have not received a COVID-19 vaccine within the last 6 months
  • Have not had a positive COVID test within 90 days prior to screening
  • Other criteria may apply*

*There are multiple studies available to participate in and each may require different criteria to be approved as a participant.

To learn more about this trial and to find out if you qualify, please call 402.934.0044 or complete the form on our Contact page.

Share This Trial, Choose Your Platform!